Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China

PHASE4CompletedINTERVENTIONAL
Enrollment

668

Participants

Timeline

Start Date

March 26, 2014

Primary Completion Date

September 18, 2017

Study Completion Date

September 18, 2017

Conditions
End Stage Renal Disease
Interventions
DEVICE

Hemodialysis treatment (no specific device is defined)

DRUG

Peritoneal Dialysis treatment (no specific drug is defined)

Trial Locations (21)

200127

Renji Hospital , Shanghai Jiaotong University , School of Medicine, Shanghai

510080

The First Affiliated Hospital , Sun Yet-Sen University, Guangzhou

Unknown

The First Affiliated Hospital of Fujian Medical University, Fuzhou

Lanzhou University Second Hospital, Lanzhou

Guangzhou Panyu Central Hospital, Guangzhou

The Third Hospital of Sun Yat-Sen University, Guangzhou

The 2nd Shenzhen Municipal People's Hospital, Shenzhen

Guizhou Province People's Hospital, Guiyang

The Second Affiliated Hospital of Harbin Medical University, Harbin

Traditional Chinese Medicine Hospital of Wuhan, Wuhan

The Third Xiangya Hospital of Central South University, Changsha

The Second Affiliated Hospital of Soochow University, Suzhou

Jiangxi province people's hospital, Nanchang

Nanchang First Affiliated Hospital, Nanchang

First Hospital of Affiliated of Dalian Medical University, Dalian

General Hospital of Ningxia Medical University, Yingchuan

Shanghai 455 Hospital, Shanghai

Shanghai Tenth People's Hospital, Shanghai

Shanghai Xinhua Hospital, Shanghai

Sichuan Provincial People's Hospital, Chengdu

The First Affiliated Hospital of Tianjin University of TCM, Tianjin

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Vantive Health LLC

INDUSTRY

NCT02378350 - Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China | Biotech Hunter | Biotech Hunter